NKTX CIK: 1787400

Nkarta, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−67.9
FY22:
−57.0
FY23:
−86.2
FY24:
−99.7
FY25:
−88.7
Change from FY21 to FY25
millions USD
FY21:
32.5
FY22:
−185
FY23:
79.0
FY24:
−130
FY25:
100
Change from FY21 to FY25
millions USD
FY21:
1.20
FY22:
219
FY23:
0.69
FY24:
226
FY25:
0.14
millions USD
FY21:
−34.2
FY22:
−22.7
FY23:
−6.45
FY24:
−3.17
FY25:
11.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−73.0
FY22:
−104
FY23:
−114
FY24:
−104
FY25:
−89.9

All amounts in millions USD Data source:SEC EDGAR